Aug 27, 2018 Drug for transthyretin amyloid cardiomyopathy curbs deaths by 30% in study Drug for transthyretin amyloid cardiomyopathy curbs deaths by 30% in studyReuters Health News | August 27, 2018. Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with transthyretin ... read morePublished on 2018-08-27